PHS
NTRA icon

PFM Health Sciences’s Natera NTRA Stock Holding History

PFM Health Sciences’s Portfolio NTRA Stock Details NTRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12M Buy
+60,004
New +$12.9M 1.09% 28
2025
Q4 		– Sell
-115,596
Closed -$18.6M – 97
2025
Q3 		$18.6M Buy
115,596
+14,346
+14% +$2.27M 1.43% 21
2025
Q2 		$17.1M Buy
+101,250
New +$15.8M 1.46% 22

Other funds holding NTRA

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PFM Health Sciences's NTRA Position: Q1 2026 in Review

PFM Health Sciences opened a new position in Natera (NTRA) in Q1 2026: 60,004 shares worth $12M. The stake represents 1.09% of the portfolio and ranks #28 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in NTRA as recently as Q3 2025.

PFM Health Sciences first reported a position in NTRA in Q2 2025 and has held it in 3 quarters since. The position peaked at $18.6M in Q3 2025. 761 funds tracked by Wall St. Rank hold NTRA as of Q1 2026.

  • PFM Health Sciences held 60,004 shares of Natera worth $12M as of Q1 2026.
  • Natera was a new PFM Health Sciences position in Q1 2026.
  • Natera made up 1.09% of PFM Health Sciences's portfolio in Q1 2026, its #28 holding.
  • PFM Health Sciences first reported a position in Natera in Q2 2025 and has held it in 3 quarters since.
  • PFM Health Sciences's Natera position peaked at $18.6M in Q3 2025.
  • 761 funds tracked by Wall St. Rank held Natera as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.